{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T14:41:39Z","timestamp":1782744099053,"version":"3.54.5"},"reference-count":26,"publisher":"BMJ","issue":"8","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Br J Ophthalmol"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1136\/bjophthalmol-2016-309219","type":"journal-article","created":{"date-parts":[[2016,12,10]],"date-time":"2016-12-10T09:08:21Z","timestamp":1481360901000},"page":"1094-1099","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":73,"title":["Topical 1% 5-fluoruracil as a sole treatment of corneoconjunctival ocular surface squamous neoplasia: long-term study"],"prefix":"10.1136","volume":"101","author":[{"given":"Raffaele","family":"Parrozzani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Frizziero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Trainiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Testi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Miglionico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Pilotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella","family":"Blandamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ambrogio","family":"Fassina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Midena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2016,12,9]]},"reference":[{"key":"key-10.1136\/bjophthalmol-2016-309219-1","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0039-6257(05)80054-2","article-title":"Ocular surface squamous neoplasia","volume":"39","author":"Lee","year":"1995","journal-title":"Surv Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-309219-2","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1016\/j.ophtha.2012.04.022","article-title":"Predictors of ocular surface squamous neoplasia recurrence after excisional surgery","volume":"119","author":"Galor","year":"2012","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2016-309219-3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/IIO.0000000000000050","article-title":"Ocular surface squamous neoplasia: evidence for topical chemotherapy","volume":"55","author":"Pe'er","year":"2015","journal-title":"Int Ophthalmol Clin"},{"key":"key-10.1136\/bjophthalmol-2016-309219-4","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/BF00166683","article-title":"Topical application of 5-fluorouracil in premalignant lesions of cornea, conjunctiva and eyelid","volume":"64","author":"de Keizer","year":"1986","journal-title":"Doc Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-309219-5","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/S0161-6420(95)30866-4","article-title":"Topical 5-fluorouracil in treating epithelial neoplasia of the conjunctiva and cornea","volume":"102","author":"Yeatts","year":"1995","journal-title":"Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-309219-6","first-page":"1000","article-title":"Conjunctival squamous cell carcinoma treated with topical 5-fluorouracil","volume":"1115","author":"Midena","year":"1997","journal-title":"Arch Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-309219-7","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1136\/bjo.84.3.268","article-title":"Treatment of conjunctival squamous cell carcinoma with topical 5- fluorouracil","volume":"811","author":"Midena","year":"2000","journal-title":"Br J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-309219-8","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1136\/bjo.2010.183244","article-title":"Topical 1% 5-fluorouracil in ocular surface squamous neoplasia: a long-term safety study","volume":"95","author":"Parrozzani","year":"2011","journal-title":"Br J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-309219-9","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1136\/bjo.2010.186171","article-title":"Adjuvant 5-fluorouracil in the treatment of localised ocular surface squamous neoplasia","volume":"95","author":"Rudkin","year":"2011","journal-title":"Br J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-309219-10","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/ceo.12184","article-title":"Long-term outcomes after adjunctival topical 5-fluorouracil or mitomycin C for the treatment of surgical-excised, localized ocular surface squamous neoplasia","volume":"42","author":"Bahrami","year":"2014","journal-title":"Clin Experiment Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-309219-11","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1016\/S0161-6420(00)00389-4","article-title":"5-fluorouracil for the treatment of intraepithelial neoplasia of the conjunctiva and cornea","volume":"107","author":"Yeatts","year":"2000","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2016-309219-12","doi-asserted-by":"crossref","first-page":"801","DOI":"10.2147\/OPTH.S9709","article-title":"5-Fluorouracil for the treatment of intraepithelial neoplasia and squamous cell carcinoma of the conjunctiva and cornea","volume":"30","author":"Al-Barrag","year":"2010","journal-title":"Clin Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-309219-13","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2165\/00003495-200767020-00005","article-title":"The clinical applications in fluorouracil in ophthalmic practice","volume":"67","author":"Abraham","year":"2007","journal-title":"Drugs"},{"key":"key-10.1136\/bjophthalmol-2016-309219-14","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/eye.2011.11","article-title":"In vivo confocal microscopy of ocular surface squamous neoplasia","volume":"25","author":"Parrozzani","year":"2011","journal-title":"Eye"},{"key":"key-10.1136\/bjophthalmol-2016-309219-15","first-page":"531","article-title":"Carcinoma of the conjunctiva","volume-title":"AJC cancer staging manual","author":"Edge","year":"2009","edition":"7"},{"key":"key-10.1136\/bjophthalmol-2016-309219-16","first-page":"1202","article-title":"Chemotherapy of neoplastic disease","volume-title":"The pharmacological basis of therapeutics","author":"Calabresi","year":"1990"},{"key":"key-10.1136\/bjophthalmol-2016-309219-17","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/ceo.12377","article-title":"Management of diffuse ocular surface squamous neoplasia: efficacy and complications of topical chemotherapy","volume":"43","author":"Rudkin","year":"2015","journal-title":"Clin Experiment Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-309219-18","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/08820530500351694","article-title":"Topical medical therapies for ocular surface tumors","volume":"21","author":"Poothullil","year":"2006","journal-title":"Semin Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-309219-19","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/ICO.0b013e31825d56c1","article-title":"Cytostatic and cytotoxic effects of 5-fluorouracil on human corneal epithelial cells and keratocytes","volume":"32","author":"Midena","year":"2013","journal-title":"Cornea"},{"key":"key-10.1136\/bjophthalmol-2016-309219-20","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1136\/bjo.2005.086850","article-title":"Complications of mitomycin C therapy in 100 eyes with ocular surface neoplasia","volume":"90","author":"Khong","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-309219-21","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/01.ico.0000148314.86557.6a","article-title":"Topical 0.002% mitomycin C for the treatment of conjunctival-corneal intraepithelial neoplasia and squamous cell carcinoma","volume":"24","author":"Prabhasawat","year":"2005","journal-title":"Cornea"},{"key":"key-10.1136\/bjophthalmol-2016-309219-22","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.ophtha.2008.01.006","article-title":"Topical interferon or surgical excision for the management of primary ocular surface squamous neoplasia","volume":"115","author":"Sturges","year":"2008","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2016-309219-23","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1001\/archophthalmol.2011.385","article-title":"Topical interferon alfa-2b for management of ocular surface squamous neoplasia in 23 cases: outcomes based on American Joint Committee on Cancer classification","volume":"130","author":"Shah","year":"2012","journal-title":"Arch Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-309219-24","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/ICO.0000000000000766","article-title":"Surgery versus interferon Alpha-2b treatment strategies for ocular surface squamous neoplasia: a literature-based decision analysis","volume":"35","author":"Siedlecki","year":"2016","journal-title":"Cornea"},{"key":"key-10.1136\/bjophthalmol-2016-309219-25","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1001\/archopht.1993.01090030068041","article-title":"Interferon-associated retinopathy","volume":"111","author":"Guyer","year":"1993","journal-title":"Arch Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-309219-26","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1001\/archopht.1995.01100080093034","article-title":"Anterior ischemic optic neuropathy secondary to interferon alfa","volume":"113","author":"Purvin","year":"1995","journal-title":"Arch Ophthalmol"}],"container-title":["British Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bjophthalmol-2016-309219","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T08:53:37Z","timestamp":1601110417000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjo.bmj.com\/lookup\/doi\/10.1136\/bjophthalmol-2016-309219"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,9]]},"references-count":26,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2017,7,18]]},"published-print":{"date-parts":[[2017,8]]}},"alternative-id":["10.1136\/bjophthalmol-2016-309219"],"URL":"https:\/\/doi.org\/10.1136\/bjophthalmol-2016-309219","relation":{},"ISSN":["0007-1161","1468-2079"],"issn-type":[{"value":"0007-1161","type":"print"},{"value":"1468-2079","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,9]]}}}